Nicholas Family Foundation Translational Research Unit celebrates 100th patient
Nurses, coordinators and other Cancer Center Clinical Trials Office staff celebrate the 100th patient for the Nicholas Family Foundation Translational Research Unit.
Nov. 13, 2013 College News - On Thursday, Nov. 7, the nurses, coordinators and pharmacists who support the Nicholas Family Foundation Translational Research Unit (TRU) celebrated its 100th patient.
James Thomas, MD, PhD, the Cancer Center’s Associate Director for Translational Research and the Medical Director of the TRU, talked about this important milestone.
"The patients we work with in the TRU are cancer researchers, just as much as our investigators and clinicians,” said Dr. Thomas. “They are participating in protocols and trials that are being tested in human beings for the very first time, and their bravery and commitment are an inspiration to all of us."
Opened in October 2013, the Nicholas Family Foundation Translational Research Unit is located in the Froedtert & the Medical College of Wisconsin Clinical Cancer Center. The TRU space is devoted to early-phase investigator-initiated cancer research trials, one of only a few in the nation with the capability to conduct early-phase cancer clinical trials in dedicated space with experienced research staff.
The TRU was built to accommodate novel “first in man” cancer treatments and support pharmacokinetic and pharmacodynamic research. For researchers and clinicians at the Medical College of Wisconsin, the TRU is a powerful tool in translating laboratory research into patient care.
The TRU is a collaborative effort of the Clinical Cancer Center and the Clinical Trials Office (CTO). The unit improves communication between patients, the treating staff and CTO research professionals in a state-of-the-art facility that promotes and supports early phase trials. The new facility attracts increased interest from industry partners for the co-development of phase I trials, and the philanthropy developed to support this unit also will fund additional early phase trials from MCW investigators.
Froedtert & the Medical College currently participate in nearly 400 clinical trials, more than any other health care system in eastern Wisconsin.